Pan Tumor Rollover Study on Long-Term Safety of Nivolumab and Other Cancer Treatments
Sponsor: Bristol-Myers Squibb
Sponsor score: 60
ClinicalTrials ID:NCT03899155
This study is focused on understanding the long-term safety of using nivolumab, alone or in combination with other cancer treatments, across different types of tumors.
Patient Parameters
| Parameter | Options |
|---|
Program Overview
The main goal of this study is to evaluate how safe nivolumab is when used by itself or with other cancer treatments over a long period. This study includes patients with various types of tumors who have been part of a previous study and are continuing their treatment.
Eligibility Criteria
Inclusion Criteria
- Must have signed a written informed consent form.
- Eligible to continue receiving treatment as per the previous study, including continuing treatment even if the cancer has progressed, as determined by the doctor in the previous study.
- Currently on a treatment break in the previous study after a long-lasting response or eligible to restart treatment as defined in the previous study.
- Women of childbearing potential and sexually active male participants must agree to use effective contraception methods as described in the consent form.
Exclusion Criteria
- Not eligible for treatment according to the previous study's criteria.
- Not experiencing any clinical benefit from the treatment as assessed by the doctor.
- Any health issue, lab result, or illness that, in the doctor's opinion, makes participation in the study not in the participant's best interest.
- Other specific inclusion and exclusion criteria as defined in the study protocol.
Locations
| FACILITY | ZIP | CITY | STATE |
|---|---|---|---|
| University of Arizona College of Medicine | 85724 | Tucson | Arizona |
| Innovative Clinical Research Institute | 90262 | Lynwood | California |
| Local Institution | 94115 | San Francisco | California |
| UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Melanoma Center | 94143 | San Francisco | California |
| University of Colorado | 80045 | Aurora | Colorado |
| Local Institution - 0095 | 06520 | New Haven | Connecticut |
| Georgetown-Lombardi Comprehensive Cancer Center | 20007-2113 | Washington | District of Columbia |
| Florida Cancer Affiliates | 34474 | Ocala | Florida |
| Local Institution | 32806 | Orlando | Florida |
| H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. | 33612 | Tampa | Florida |
Get This Program In Your Inbox
Receive detailed information about this treatment opportunity to review with your healthcare provider.